je.st
news
Tag: agilent
Agilent Technologies Introduces New Atomic Spectroscopy Platform For Multiple Analytical Applications
2016-05-06 06:50:10| metrologyworld Home Page
Agilent Technologies Inc. recently introduced a new addition to its lineup of inductively coupled plasma-optical emission spectrometers
Tags: multiple
applications
technologies
platform
Agilent Technologies And Applied Spectral Imaging Announce Co-Marketing Agreement For Fluorescence In Situ Hybridization
2016-04-11 03:20:20| chemicalonline Home Page
Agilent Technologies Inc.,and Applied Spectral Imaging (ASI) recentlyannounced they have entered into an agreement to jointly market ASI’s most advanced GenASIs imaging platforms and Agilent’s fluorescence in situ hybridization (FISH) products and solutions, including its Dako Omnis instrument for automated FISH sample processing
Tags: agreement
technologies
applied
imaging
Agilent Technologies Receives Award For Outstanding Customer Service For Second Straight Year
2016-03-21 01:29:52| chemicalonline Home Page
Agilent Technologies Inc. recentlyannounced it has been recognized with the 2016 Reviewers’ Choice Award for Customer Service from SelectScience, an independent, expert-led scientific review
Tags: service
year
customer
customer service
Agilent, Apple and Canadian Pacific Are Among Larry Robbins' New Buys
2015-12-22 20:01:33| Railroads - Topix.net
Robbins founded Glenview Capital Management in 2000 as a privately held investment management firm and is focused on delivering attractive absolute returns through an intense focus on deep fundamental research and individual security selection. The largest new buy was Agilent Technologies Inc. .
Tags: new
apple
pacific
canadian
Merck and Pfizer Collaborate with Dako, an Agilent Technologies...
2015-09-25 14:54:44| Biotech - Topix.net
As part of the global strategic alliance between Merck and Pfizer to jointly develop and commercialize avelumab*, an investigational immune checkpoint inhibitor, the companies have announced that they have a collaboration agreement in place with Dako, an Agilent Technologies company, for the development of a potential companion diagnostic test . The three-party agreement, signed recently, enables Dako, Merck and Pfizer to work to develop the CDx to assess programmed death-ligand 1 protein expression levels in tumor tissue, and its microenvironment, including tumor-associated immune cells.
Tags: technologies
collaborate
merck
pfizer